SCHEMBL10110397

SCHEMBL10110397

c1ccc(-c2ccc(-c3ccc(N(c4cccc(-c5ccc(-c6ccc7oc8ccccc8c7c6)cc5)c4)c4cccc5ccccc45)cc3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 4/20 0.40
▸ PLA2G4A P47712 4/20 0.40
▸ PLA2G10 O15496 1/20 0.39
▸ CASP3 P42574 1/20 0.37
▸ SENP7 Q9BQF6 1/20 0.37
▸ SENP6 Q9GZR1 1/20 0.37
▸ KDM4E B2RXH2 5/20 0.36
▸ MAPT P10636 4/20 0.36
▸ HPGD P15428 4/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ TSHR P16473 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ GLA P06280 2/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10110199 1.00 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10CASP3SENP7
SCHEMBL10110342 0.99 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10CASP3SENP7
SCHEMBL10110345 0.99 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10CASP3SENP7
SCHEMBL10110402 0.99 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10CASP3SENP7
SCHEMBL10110208 0.99 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10CASP3SENP7
SCHEMBL19099918 0.96 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10CASP3SENP7
SCHEMBL20462422 0.96 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10CASP3SENP7
SCHEMBL10109981 0.96 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10CASP3SENP7
SCHEMBL17126412 0.96 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10CASP3SENP7
SCHEMBL6372671 0.96 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10CASP3SENP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9087997-B2 Aromatic amine derivative and organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2015-07-21 — — US disclosed
US-9087997-B2 Aromatic amine derivative and organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2015-07-21 — — US disclosed
US-8703304-B2 Aromatic amine derivative and organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2014-04-22 — — US disclosed
US-8703304-B2 Aromatic amine derivative and organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2014-04-22 — — US disclosed
US-20140061630-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2014-03-06 — — US disclosed
US-20140061630-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2014-03-06 — — US disclosed
US-20120161119-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120161119-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE TYR, TERF2, SAT1 PLA2G2A 4230/4885PLA2G4A 4705/4885PLA2G10 4328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback